Oral Wegovy Tablets
(Daily Semaglutide Pill)

You can buy oral Wegovy online through Prescriptly's secure platform. Simply complete our brief 5-minute medical questionnaire. One of our UK-registered clinicians will review your answers to ensure it is safe and suitable for you. Once approved, your Wegovy tablets are dispensed from our GPhC-registered pharmacy and delivered discreetly to your door with next-day delivery.

Yes, clinical trials have shown that oral Wegovy (daily tablets) provides similar weight loss results to the once-weekly injections when taken as directed. The active ingredient, semaglutide, works the exact same way in both forms to reduce appetite and keep you fuller for longer.

Yes, ordering Wegovy pills online is completely safe as long as you use a regulated provider. Prescriptly is a fully GPhC-registered UK pharmacy. All prescriptions are issued by licensed UK clinicians following strict MHRA guidelines. We only dispense genuine, MHRA-approved medications.

Wegovy (Semaglutide) is a single-action GLP-1 receptor agonist and is the pioneer in this class of weight loss medications. Mounjaro (Tirzepatide) is a newer medication that activates both GIP and GLP-1 receptors simultaneously. While clinical trials show Mounjaro produces a slightly higher average weight loss (up to 22.5% vs 15%), Wegovy has a longer history of real-world use and proven cardiovascular benefits. Both are highly effective treatments.

Most patients notice a reduction in appetite and food cravings within the first 1–2 weeks of starting Wegovy. Visible weight loss typically becomes apparent by weeks 4–8. The most significant weight loss phase occurs between months 3 and 9 as doses are titrated upward. Average weight loss in the STEP trials reached around 15%.

All new patients start on Wegovy 0.25mg once weekly for the first 4 weeks. The dose is then increased every 4 weeks through 0.5mg, 1.0mg, 1.7mg, and up to 2.4mg. Our clinical team will guide your titration based on your tolerability and response.

NICE has approved Semaglutide (Wegovy) for NHS use in England, but access through NHS pathways remains limited to specialist tier-3 obesity services, which have significant waiting lists. Most patients who want to start Wegovy now access it through a private prescription service like Prescriptly. NHS provision is expected to expand gradually over the coming years as the specialist services scale up.

Yes — and switching is straightforward. Tell us your current dose during the consultation questionnaire and our prescribers will continue you at your existing dose without restarting titration. We time your first delivery so there is no gap in your medication, and we will guide you through cancelling with your previous provider if needed.

Wegovy oral is taken as a single tablet once a day. You must take it on a completely empty stomach with a small sip of water (no more than 120ml). It is critical that you wait at least 30 minutes before eating, drinking, or taking any other medications, otherwise the tablet will not be absorbed. We include full instructions with every order, and our clinical team is available to help if you have any questions.

Wegovy is not suitable if you are pregnant, breastfeeding, or planning a pregnancy. It is contraindicated for those with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should also be avoided if you have severe gastrointestinal disease (like severe gastroparesis), a history of pancreatitis, or severe kidney impairment. Our comprehensive medical questionnaire will screen for all of these contraindications to ensure your safety.

Yes. Wegovy is a highly effective tool that makes eating less feel natural, but it is not a standalone magic cure. It is clinically licensed to be used as an adjunct to a reduced-calorie diet and increased physical activity. Incorporating a balanced, high-protein diet and regular resistance training will not only maximize your weight loss but also help preserve lean muscle mass during your treatment.

If you miss a dose of Wegovy and it has been 4 days (96 hours) or less since your scheduled dose, administer it as soon as possible. If more than 4 days have passed, skip the missed dose and administer your next dose on your regularly scheduled day. Do not administer two doses within 3 days (72 hours) of each other. If you miss multiple consecutive doses, contact our clinical team before resuming, as you may need to restart at a lower dose to avoid gastrointestinal side effects.

Unlike the Wegovy injection, Wegovy tablets do not need to be stored in a refrigerator. You should store them at room temperature (below 30°C) in a dry place. Keep the tablets in their original blister pack to protect them from moisture and light until you are ready to take your dose.

Yes, obesity is increasingly recognized as a chronic metabolic condition, and Wegovy is designed and licensed for long-term weight management. Clinical trials have demonstrated its safety profile over extended periods. Stopping the medication usually results in a return of appetite and potential weight regain, which is why many patients opt to stay on a lower maintenance dose long-term. Our clinical team will work with you to establish the safest and most effective long-term plan for your biology.